Aras Emre Canda

14PUBLICATIONS
26CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Nov 05, 2025
Can neoadjuvant chemoradiotherapy be omitted in cT2N+ and cT3 mid-rectal cancer: Protocol for a prospective, observational, cohort study (CANO).

Feza Karakayali, Cigdem Arslan, Tayfun Bisgin

|Apr 01, 2024
In vitro 3D microfluidic peritoneal metastatic colorectal cancer model for testing different oxaliplatin-based HIPEC regimens.

Aras Emre Canda, Tolga Sever, Gizem Calibasi Kocal

|Mar 27, 2023
Diagnostic performance of magnetic resonance imaging in preoperative local staging of rectal cancer after neoadjuvant chemoradiotherapy

Hakkı Çelik, Funda Barlık, Selman Sökmen

|Feb 22, 2020
The impact of sarcopenia on morbidity and long-term survival among patients with peritoneal metastases of colorectal origin treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a 10-year longitudinal analysis of a single-center experience.

C Agalar, S Sokmen, C Arslan

|Sep 07, 2019
Cross-sectional areas of rectus abdominis and psoas muscles reduces following surgery in rectal cancer patients.

Oguz Yuksel, Naciye Sinem Gezer, Aras Emre Canda

|Apr 07, 2018
Reply to Comment to: Preventing parastomal hernia with modified stapled mesh stoma reinforcement technique (SMART) in patients who underwent surgery for rectal cancer: a case-control study. Li J, Zhang W.

A E Canda, C Terzi, C Agalar

Pageof 3

Frequent Collaborators

3 joint publications

Semra Demirli Atici

3 joint publications

Funda Obuz

3 joint publications

Mustafa Cem Terzi

2 joint publications

Cihan Ağalar